Andere Kunden interessierten sich auch für
![Studies with beta particle emitting radionuclide for cancer therapy]( "Studies with beta particle emitting radionuclide for cancer therapy")
Studies with beta particle emitting radionuclide for cancer therapy32,99 €![Comparison of the anticancer effects of panobinostat with doxorubicin]( "Comparison of the anticancer effects of panobinostat with doxorubicin")
Comparison of the anticancer effects of panobinostat with doxorubicin23,99 €![Human Mesenchymal Stem Cells and Breast Carcinoma]( "Human Mesenchymal Stem Cells and Breast Carcinoma")
Human Mesenchymal Stem Cells and Breast Carcinoma42,99 €![Srawnenie protiworakowyh äffektow panobinostata i doxorubicina]( "Srawnenie protiworakowyh äffektow panobinostata i doxorubicina")
Srawnenie protiworakowyh äffektow panobinostata i doxorubicina13,99 €![Issledowaniq radionuklidow, izluchaüschih beta-chasticy, dlq lecheniq raka]( "Issledowaniq radionuklidow, izluchaüschih beta-chasticy, dlq lecheniq raka")
Issledowaniq radionuklidow, izluchaüschih beta-chasticy, dlq lecheniq raka16,99 €![Studien mit Betateilchen emittierenden Radionukliden für die Krebstherapie]( "Studien mit Betateilchen emittierenden Radionukliden für die Krebstherapie")
Studien mit Betateilchen emittierenden Radionukliden für die Krebstherapie49,90 €![Design and Evaluation of Plasmonic/Magnetic Au-MFe2O4 (M-Fe/Co/Mn) Core-Shell Nanoparticles Functionalized with Doxorubicin for Cancer Therapeutics]( "Design and Evaluation of Plasmonic/Magnetic Au-MFe2O4 (M-Fe/Co/Mn) Core-Shell Nanoparticles Functionalized with Doxorubicin for Cancer Therapeutics")
Design and Evaluation of Plasmonic/Magnetic Au-MFe2O4 (M-Fe/Co/Mn) Core-Shell Nanoparticles Functionalized with Doxorubicin for Cancer Therapeutics74,99 €
A comparative study of cardio protective activity of nebivolol, carvedilol and metoprolol was carried out on doxorubicin-induced cardiac toxicity in rats. The degree of protection was assessed both in vivo by short axis echocardiography measuring ejection fraction (EF), fractional shortening (FS), left ventricular systolic diameter (LVSD) and left ventricular diastolic diameter (LVDD) and in vitro by measuring the inotropic and the chronotropic responses to isoproterenol. Also histopathlogical study was done. This study revealed that there is a significant improvement of cardiac functions in rats treated with beta-blockers and there is no significant difference between carvedilol and nebivolol whereas nebivolol has the best histopathological score for improvement cardiac toxicity.